Xvivo Perfusion AB (publ) (XVIPF)
USD 41.1
(0.0%)
USD 41.1
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -214.65 Million SEK | 9.25% |
| 2022 | -236.54 Million SEK | 39.81% |
| 2021 | -392.97 Million SEK | -13.5% |
| 2020 | -346.22 Million SEK | -125.41% |
| 2019 | -153.59 Million SEK | 17.54% |
| 2018 | -186.26 Million SEK | 4.49% |
| 2017 | -195.02 Million SEK | -734.46% |
| 2016 | -23.37 Million SEK | 43.04% |
| 2015 | -41.03 Million SEK | 14.87% |
| 2014 | -48.2 Million SEK | -2006.76% |
| 2013 | 2.52 Million SEK | 92.54% |
| 2012 | 1.31 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -480.24 Million SEK | -123.73% |
| 2024 Q2 | -453.58 Million SEK | 5.55% |
| 2024 Q3 | -449.98 Million SEK | 0.79% |
| 2023 FY | -214.65 Million SEK | 9.25% |
| 2023 Q4 | -214.65 Million SEK | 62.26% |
| 2023 Q1 | 95.03 Million SEK | 140.18% |
| 2023 Q2 | 113.65 Million SEK | 19.6% |
| 2023 Q3 | -568.73 Million SEK | -600.39% |
| 2022 Q4 | -236.54 Million SEK | 23.45% |
| 2022 Q3 | -309.01 Million SEK | 0.79% |
| 2022 Q2 | -311.46 Million SEK | 6.93% |
| 2022 Q1 | -334.64 Million SEK | 14.84% |
| 2022 FY | -236.54 Million SEK | 39.81% |
| 2021 Q4 | -392.97 Million SEK | -40.43% |
| 2021 Q1 | -343.42 Million SEK | 0.81% |
| 2021 Q2 | -305.62 Million SEK | 11.01% |
| 2021 Q3 | -279.84 Million SEK | 8.44% |
| 2021 FY | -392.97 Million SEK | -13.5% |
| 2020 Q1 | -148.5 Million SEK | 3.31% |
| 2020 Q2 | -92.12 Million SEK | 37.96% |
| 2020 Q3 | -533.88 Million SEK | -479.51% |
| 2020 Q4 | -346.22 Million SEK | 35.15% |
| 2020 FY | -346.22 Million SEK | -125.41% |
| 2019 Q1 | -121.42 Million SEK | 34.81% |
| 2019 FY | -153.59 Million SEK | 17.54% |
| 2019 Q3 | -126.59 Million SEK | 3.26% |
| 2019 Q2 | -130.86 Million SEK | -7.77% |
| 2019 Q4 | -153.59 Million SEK | -21.33% |
| 2018 FY | -186.26 Million SEK | 4.49% |
| 2018 Q2 | -171.02 Million SEK | -4.83% |
| 2018 Q3 | -160.42 Million SEK | 6.2% |
| 2018 Q4 | -186.26 Million SEK | -16.11% |
| 2018 Q1 | -163.14 Million SEK | 16.34% |
| 2017 Q2 | -174.27 Million SEK | -2096.7% |
| 2017 Q1 | 8.72 Million SEK | 137.35% |
| 2017 Q3 | -170.63 Million SEK | 2.09% |
| 2017 Q4 | -195.02 Million SEK | -14.29% |
| 2017 FY | -195.02 Million SEK | -734.46% |
| 2016 Q2 | -41.77 Million SEK | 2.21% |
| 2016 Q1 | -42.72 Million SEK | -4.11% |
| 2016 FY | -23.37 Million SEK | 43.04% |
| 2016 Q4 | -23.37 Million SEK | 41.65% |
| 2016 Q3 | -40.05 Million SEK | 4.13% |
| 2015 Q1 | -39.66 Million SEK | 17.72% |
| 2015 FY | -41.03 Million SEK | 14.87% |
| 2015 Q4 | -41.03 Million SEK | 3.67% |
| 2015 Q3 | -42.59 Million SEK | -2.3% |
| 2015 Q2 | -41.63 Million SEK | -4.98% |
| 2014 Q2 | 13.37 Million SEK | 38.15% |
| 2014 Q1 | 9.68 Million SEK | 283.07% |
| 2014 FY | -48.2 Million SEK | -2006.76% |
| 2014 Q4 | -48.2 Million SEK | 12.46% |
| 2014 Q3 | -55.06 Million SEK | -511.6% |
| 2013 Q2 | -1.07 Million SEK | -5.8% |
| 2013 Q4 | 2.52 Million SEK | -16.07% |
| 2013 Q1 | -1.01 Million SEK | -177.53% |
| 2013 FY | 2.52 Million SEK | 92.54% |
| 2013 Q3 | 3.01 Million SEK | 379.67% |
| 2012 FY | 1.31 Million SEK | 0.0% |
| 2012 Q4 | 1.31 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | -718.291% |
| Manhattan Scientifics, Inc. | -7000.00 USD | -3066342.857% |
| Össur hf. | 395.08 Million USD | 154.331% |
| QHSLab, Inc. | 1.72 Million USD | 12507.787% |
| Wellstar International, Inc. | 51.36 Million USD | 517.878% |
| Össur hf. | 395.08 Million USD | 154.331% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | 68095.096% |
| Aurora Spine Corporation | 1.9 Million USD | 11352.087% |
| BrainsWay Ltd. | -10.32 Million USD | -1979.952% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 1547.747% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 1284.213% |
| Vivos Inc. | -1.59 Million USD | -13380.673% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 44146.063% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | -39577.737% |
| Zecotek Photonics Inc. | 2.76 Million USD | 7870.313% |
| Avitar, Inc. | 5.17 Million USD | 4250.928% |
| Nanomix Corporation | 11.38 Million USD | 1984.696% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | -4548.972% |
| Theraclion SA | -5.86 Million EUR | -3560.154% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | 1.68 Million USD | 12824.734% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 13425.391% |
| Lombard Medical, Inc. | 11.49 Million USD | 1967.342% |
| ALR Technologies Inc. | 19.14 Million USD | 1220.996% |
| Stratec SE | 119.12 Million USD | 280.191% |
| Vycor Medical, Inc. | 1.05 Million USD | 20485.543% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 390410.028% |
| MicroPort Scientific Corporation | 673.58 Million USD | 131.867% |
| VMS Rehab Systems, Inc. | 133.52 USD | 160763281.546% |
| NewCardio, Inc. | 2.41 Million USD | 8988.144% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 14731.98% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 34121.958% |
| Odyssey Group International, Inc. | 2.1 Million USD | 10283.675% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 33628.898% |
| Wellness Center USA, Inc. | 3.98 Million USD | 5485.821% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 812.014% |
| IR-Med Inc. | -606 Thousand USD | -35320.957% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | -1456.877% |
| Polarean Imaging plc | -5.94 Million USD | -3509.681% |
| United American Healthcare Corporation | -9.32 Million USD | -2201.394% |
| ECGI Holdings, Inc. | 3.17 Million USD | 6868.671% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 230427.06% |
| Capital Group Holdings, Inc. | -3508.00 USD | -6118799.658% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 81835.068% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 99196.525% |
| Urologix, Inc. | 4.61 Million USD | 4751.159% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 5199.297% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 6543.563% |
| SS Innovations International, Inc. | 1.18 Million USD | 18208.736% |
| Qualis Innovations, Inc. | 6671.00 USD | 3217773.512% |
| Smith & Nephew plc | 2.77 Billion USD | 107.727% |
| NIOX Group Plc | -23.93 Million USD | -796.905% |
| Fuse Medical, Inc. | 1.75 Million USD | 12327.377% |
| Broncus Holding Corporation | -81.42 Million USD | -163.618% |
| Brain Scientific Inc. | 2.11 Million USD | 10245.285% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 1046.555% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 542737.207% |